Interestingly CRP, a marker of systemic inflammatory state and considered a marker for joint “activity” as well as marker for metabolic and cardiovascular risk, tended to lower levels during follow-up in patients with gout associated with MetS, but not in patients without it. The gene discussed is CRP; the disease is gout.